To uncover the mission of GRO Biosciences Inc., one has to look no further than its name. The acronym stands for “genomically recoded organisms”
Read More
Harvard geneticist and serial biotech entrepreneur George Church has co-founded a new startup that aims to develop “designer proteins” targeting a range of disorders.
GRO Biosciences Inc. wants to make a giant sector in the pharmaceutical industry even larger. The spinout from the lab of Harvard Medical School geneticist George Church aims to make protein drugs more versatile and effective
Biology is computation. It operates on the digital alphabet of biochemistry, which is quite a bit more complicated than binary, hex, or even Haskell.
BOSTON, Sept. 28, 2017 – GRO Biosciences Inc. today announced that the company has secured $2.1 million in a seed funding round co-led by Digitalis Ventures and Eric Schmidt’s Innovation Endeavors.
